| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |